Valuation: Terumo Corporation

Market Cap 3,301B 20.98B 18.33B 17.23B 15.72B 29.51B 2,005B 29.51B 207B 79.79B 1,024B 78.77B 77.05B P/E 2027 *
17.6x
P/E 2028 * 17.2x
Enterprise Value 3,347B 21.27B 18.59B 17.47B 15.94B 29.92B 2,033B 29.92B 210B 80.9B 1,038B 79.87B 78.12B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.45x
Free-Float
97.34%
Yield 2027 *
1.66%
Yield 2028 * 1.81%
1 day-2.33%
1 week-0.20%
Current month-11.05%
1 month-12.88%
3 months-0.29%
6 months+9.76%
Current year-1.41%
1 week 2,228.5
Extreme 2228.5
2,294.5
1 month 2,194.5
Extreme 2194.5
2,645.5
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%-0.20%-8.89%+8.91% 20.98B
+0.69%+1.63%-24.10%+5.64% 179B
-1.07%-3.18%-4.07%+13.08% 116B
-0.65%-2.74%+8.88%+69.09% 60B
+1.27%-1.57%-1.90%-31.00% 49.85B
-0.22%+1.23%+7.80%+45.79% 48.05B
+0.40%+3.56%+28.80%+2.32% 33.79B
+7.73%+7.23% - - 30.21B
+2.57%+1.67%+47.13%-0.38% 26.12B
-0.68%+5.62%+9.40%-9.70% 22.98B
Average +0.92%+1.47%+7.00%+11.53% 58.75B
Weighted average by Cap. +0.67%+0.41%-3.14%+13.22%

Financials

2027 *2028 *
Net sales 1,259B 8B 6.99B 6.57B 6B 11.25B 765B 11.25B 78.85B 30.43B 390B 30.04B 29.38B 1,339B 8.51B 7.44B 6.99B 6.38B 11.97B 813B 11.97B 83.88B 32.37B 415B 31.96B 31.26B
Net income 188B 1.19B 1.04B 981M 895M 1.68B 114B 1.68B 11.77B 4.54B 58.31B 4.49B 4.39B 192B 1.22B 1.07B 1B 915M 1.72B 117B 1.72B 12.03B 4.64B 59.59B 4.58B 4.48B
Net Debt 45.99B 292M 255M 240M 219M 411M 27.94B 411M 2.88B 1.11B 14.27B 1.1B 1.07B -26.39B -168M -147M -138M -126M -236M -16.03B -236M -1.65B -638M -8.19B -630M -616M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
18/09/26 JP¥2,238.00 -2.33% 6,326,500
17/09/26 JP¥2,291.50 +2.12% 3,177,500
16/09/26 JP¥2,244.00 +0.07% 2,879,300
15/09/26 JP¥2,242.50 -0.88% 2,588,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,238.00JPY
Average target price
3,110.00JPY
Spread / Average Target
+38.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!